nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A5—Sulfasalazine—Crohn's disease	0.0613	0.546	CbGbCtD
Fentanyl—ABCB1—Prednisone—Crohn's disease	0.0319	0.284	CbGbCtD
Fentanyl—CYP3A4—Prednisone—Crohn's disease	0.0191	0.17	CbGbCtD
Fentanyl—Infestation—Azathioprine—Crohn's disease	0.00175	0.00211	CcSEcCtD
Fentanyl—Angina pectoris—Mesalazine—Crohn's disease	0.00174	0.0021	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00173	0.00209	CcSEcCtD
Fentanyl—Contusion—Prednisone—Crohn's disease	0.00173	0.00208	CcSEcCtD
Fentanyl—Bronchitis—Mesalazine—Crohn's disease	0.00172	0.00207	CcSEcCtD
Fentanyl—Abdominal discomfort—Mesalazine—Crohn's disease	0.00171	0.00207	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0017	0.00206	CcSEcCtD
Fentanyl—Pancytopenia—Mesalazine—Crohn's disease	0.0017	0.00205	CcSEcCtD
Fentanyl—Neutropenia—Mesalazine—Crohn's disease	0.00167	0.00202	CcSEcCtD
Fentanyl—Dysuria—Mesalazine—Crohn's disease	0.00167	0.00202	CcSEcCtD
Fentanyl—Viral infection—Prednisone—Crohn's disease	0.00167	0.00201	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00166	0.002	CcSEcCtD
Fentanyl—Arthropathy—Prednisone—Crohn's disease	0.00166	0.002	CcSEcCtD
Fentanyl—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00165	0.002	CcSEcCtD
Fentanyl—Pollakiuria—Mesalazine—Crohn's disease	0.00165	0.00199	CcSEcCtD
Fentanyl—Decreased appetite—Mercaptopurine—Crohn's disease	0.00163	0.00196	CcSEcCtD
Fentanyl—Weight increased—Mesalazine—Crohn's disease	0.00162	0.00196	CcSEcCtD
Fentanyl—Weight decreased—Mesalazine—Crohn's disease	0.00162	0.00195	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00162	0.00195	CcSEcCtD
Fentanyl—Pneumonia—Mesalazine—Crohn's disease	0.0016	0.00193	CcSEcCtD
Fentanyl—Infestation—Mesalazine—Crohn's disease	0.00159	0.00192	CcSEcCtD
Fentanyl—Infestation NOS—Mesalazine—Crohn's disease	0.00159	0.00192	CcSEcCtD
Fentanyl—Ulcer—Prednisone—Crohn's disease	0.00159	0.00192	CcSEcCtD
Fentanyl—Depression—Mesalazine—Crohn's disease	0.00159	0.00192	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00158	0.00191	CcSEcCtD
Fentanyl—Haemoglobin—Azathioprine—Crohn's disease	0.00158	0.0019	CcSEcCtD
Fentanyl—Haemorrhage—Azathioprine—Crohn's disease	0.00157	0.00189	CcSEcCtD
Fentanyl—Renal failure—Mesalazine—Crohn's disease	0.00156	0.00189	CcSEcCtD
Fentanyl—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00156	0.00188	CcSEcCtD
Fentanyl—Stomatitis—Mesalazine—Crohn's disease	0.00155	0.00187	CcSEcCtD
Fentanyl—Jaundice—Mesalazine—Crohn's disease	0.00155	0.00187	CcSEcCtD
Fentanyl—Urinary tract infection—Mesalazine—Crohn's disease	0.00155	0.00187	CcSEcCtD
Fentanyl—Conjunctivitis—Mesalazine—Crohn's disease	0.00155	0.00187	CcSEcCtD
Fentanyl—Sweating—Mesalazine—Crohn's disease	0.00153	0.00184	CcSEcCtD
Fentanyl—Haematuria—Mesalazine—Crohn's disease	0.00152	0.00183	CcSEcCtD
Fentanyl—Hiccups—Prednisone—Crohn's disease	0.00151	0.00182	CcSEcCtD
Fentanyl—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00151	0.00182	CcSEcCtD
Fentanyl—Epistaxis—Mesalazine—Crohn's disease	0.0015	0.00181	CcSEcCtD
Fentanyl—Sinusitis—Mesalazine—Crohn's disease	0.00149	0.0018	CcSEcCtD
Fentanyl—Erythema multiforme—Azathioprine—Crohn's disease	0.00148	0.00179	CcSEcCtD
Fentanyl—Body temperature increased—Mercaptopurine—Crohn's disease	0.00148	0.00179	CcSEcCtD
Fentanyl—Haemoglobin—Mesalazine—Crohn's disease	0.00144	0.00173	CcSEcCtD
Fentanyl—Rhinitis—Mesalazine—Crohn's disease	0.00143	0.00173	CcSEcCtD
Fentanyl—Fluid retention—Prednisone—Crohn's disease	0.00143	0.00173	CcSEcCtD
Fentanyl—Haemorrhage—Mesalazine—Crohn's disease	0.00143	0.00173	CcSEcCtD
Fentanyl—Pharyngitis—Mesalazine—Crohn's disease	0.00142	0.00171	CcSEcCtD
Fentanyl—Immune system disorder—Azathioprine—Crohn's disease	0.00142	0.00171	CcSEcCtD
Fentanyl—Mediastinal disorder—Azathioprine—Crohn's disease	0.00141	0.00171	CcSEcCtD
Fentanyl—Neuropathy—Prednisone—Crohn's disease	0.00141	0.00171	CcSEcCtD
Fentanyl—Urinary tract disorder—Mesalazine—Crohn's disease	0.00141	0.0017	CcSEcCtD
Fentanyl—Oedema peripheral—Mesalazine—Crohn's disease	0.00141	0.0017	CcSEcCtD
Fentanyl—Chills—Azathioprine—Crohn's disease	0.00141	0.0017	CcSEcCtD
Fentanyl—Connective tissue disorder—Mesalazine—Crohn's disease	0.0014	0.0017	CcSEcCtD
Fentanyl—Arrhythmia—Azathioprine—Crohn's disease	0.0014	0.00169	CcSEcCtD
Fentanyl—Urethral disorder—Mesalazine—Crohn's disease	0.0014	0.00169	CcSEcCtD
Fentanyl—Alopecia—Azathioprine—Crohn's disease	0.00139	0.00167	CcSEcCtD
Fentanyl—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00138	0.00166	CcSEcCtD
Fentanyl—Oesophagitis—Prednisone—Crohn's disease	0.00138	0.00166	CcSEcCtD
Fentanyl—Ecchymosis—Prednisone—Crohn's disease	0.00136	0.00164	CcSEcCtD
Fentanyl—Erythema multiforme—Mesalazine—Crohn's disease	0.00135	0.00163	CcSEcCtD
Fentanyl—Eye disorder—Mesalazine—Crohn's disease	0.00134	0.00161	CcSEcCtD
Fentanyl—Tinnitus—Mesalazine—Crohn's disease	0.00133	0.00161	CcSEcCtD
Fentanyl—Cardiac disorder—Mesalazine—Crohn's disease	0.00133	0.0016	CcSEcCtD
Fentanyl—Sepsis—Prednisone—Crohn's disease	0.00131	0.00158	CcSEcCtD
Fentanyl—Angiopathy—Mesalazine—Crohn's disease	0.0013	0.00157	CcSEcCtD
Fentanyl—Euphoric mood—Prednisone—Crohn's disease	0.00129	0.00156	CcSEcCtD
Fentanyl—Immune system disorder—Mesalazine—Crohn's disease	0.00129	0.00156	CcSEcCtD
Fentanyl—Mediastinal disorder—Mesalazine—Crohn's disease	0.00129	0.00155	CcSEcCtD
Fentanyl—Chills—Mesalazine—Crohn's disease	0.00128	0.00155	CcSEcCtD
Fentanyl—Diarrhoea—Mercaptopurine—Crohn's disease	0.00128	0.00155	CcSEcCtD
Fentanyl—Ill-defined disorder—Azathioprine—Crohn's disease	0.00127	0.00153	CcSEcCtD
Fentanyl—Alopecia—Mesalazine—Crohn's disease	0.00126	0.00152	CcSEcCtD
Fentanyl—Thrombophlebitis—Prednisone—Crohn's disease	0.00126	0.00152	CcSEcCtD
Fentanyl—Anaemia—Azathioprine—Crohn's disease	0.00126	0.00152	CcSEcCtD
Fentanyl—Mental disorder—Mesalazine—Crohn's disease	0.00125	0.00151	CcSEcCtD
Fentanyl—Erythema—Mesalazine—Crohn's disease	0.00124	0.0015	CcSEcCtD
Fentanyl—Malaise—Azathioprine—Crohn's disease	0.00123	0.00149	CcSEcCtD
Fentanyl—Flatulence—Mesalazine—Crohn's disease	0.00123	0.00148	CcSEcCtD
Fentanyl—Leukopenia—Azathioprine—Crohn's disease	0.00122	0.00148	CcSEcCtD
Fentanyl—Tension—Mesalazine—Crohn's disease	0.00122	0.00147	CcSEcCtD
Fentanyl—Dysgeusia—Mesalazine—Crohn's disease	0.00122	0.00147	CcSEcCtD
Fentanyl—Nervousness—Mesalazine—Crohn's disease	0.00121	0.00146	CcSEcCtD
Fentanyl—Back pain—Mesalazine—Crohn's disease	0.0012	0.00145	CcSEcCtD
Fentanyl—Muscle spasms—Mesalazine—Crohn's disease	0.0012	0.00144	CcSEcCtD
Fentanyl—Vomiting—Mercaptopurine—Crohn's disease	0.00119	0.00144	CcSEcCtD
Fentanyl—Injury—Prednisone—Crohn's disease	0.00119	0.00144	CcSEcCtD
Fentanyl—Rash—Mercaptopurine—Crohn's disease	0.00118	0.00142	CcSEcCtD
Fentanyl—Dermatitis—Mercaptopurine—Crohn's disease	0.00118	0.00142	CcSEcCtD
Fentanyl—Vision blurred—Mesalazine—Crohn's disease	0.00117	0.00142	CcSEcCtD
Fentanyl—Tremor—Mesalazine—Crohn's disease	0.00117	0.00141	CcSEcCtD
Fentanyl—Increased appetite—Prednisone—Crohn's disease	0.00116	0.0014	CcSEcCtD
Fentanyl—Amnesia—Prednisone—Crohn's disease	0.00116	0.0014	CcSEcCtD
Fentanyl—Arthralgia—Azathioprine—Crohn's disease	0.00116	0.0014	CcSEcCtD
Fentanyl—Myalgia—Azathioprine—Crohn's disease	0.00116	0.0014	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00115	0.00139	CcSEcCtD
Fentanyl—Ill-defined disorder—Mesalazine—Crohn's disease	0.00115	0.00139	CcSEcCtD
Fentanyl—Anaemia—Mesalazine—Crohn's disease	0.00115	0.00139	CcSEcCtD
Fentanyl—Discomfort—Azathioprine—Crohn's disease	0.00115	0.00139	CcSEcCtD
Fentanyl—Malaise—Mesalazine—Crohn's disease	0.00112	0.00135	CcSEcCtD
Fentanyl—Vertigo—Mesalazine—Crohn's disease	0.00112	0.00135	CcSEcCtD
Fentanyl—Syncope—Mesalazine—Crohn's disease	0.00112	0.00135	CcSEcCtD
Fentanyl—Lethargy—Prednisone—Crohn's disease	0.00112	0.00135	CcSEcCtD
Fentanyl—Leukopenia—Mesalazine—Crohn's disease	0.00111	0.00134	CcSEcCtD
Fentanyl—Nausea—Mercaptopurine—Crohn's disease	0.00111	0.00134	CcSEcCtD
Fentanyl—Infection—Azathioprine—Crohn's disease	0.00111	0.00134	CcSEcCtD
Fentanyl—Palpitations—Mesalazine—Crohn's disease	0.0011	0.00133	CcSEcCtD
Fentanyl—Loss of consciousness—Mesalazine—Crohn's disease	0.00109	0.00132	CcSEcCtD
Fentanyl—Osteoarthritis—Prednisone—Crohn's disease	0.00109	0.00132	CcSEcCtD
Fentanyl—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00109	0.00132	CcSEcCtD
Fentanyl—Thrombocytopenia—Azathioprine—Crohn's disease	0.00109	0.00132	CcSEcCtD
Fentanyl—Cough—Mesalazine—Crohn's disease	0.00109	0.00131	CcSEcCtD
Fentanyl—Skin disorder—Azathioprine—Crohn's disease	0.00108	0.00131	CcSEcCtD
Fentanyl—Affect lability—Prednisone—Crohn's disease	0.00108	0.0013	CcSEcCtD
Fentanyl—Hypertension—Mesalazine—Crohn's disease	0.00107	0.0013	CcSEcCtD
Fentanyl—Psychotic disorder—Prednisone—Crohn's disease	0.00107	0.00129	CcSEcCtD
Fentanyl—Arthralgia—Mesalazine—Crohn's disease	0.00106	0.00128	CcSEcCtD
Fentanyl—Chest pain—Mesalazine—Crohn's disease	0.00106	0.00128	CcSEcCtD
Fentanyl—Myalgia—Mesalazine—Crohn's disease	0.00106	0.00128	CcSEcCtD
Fentanyl—Anxiety—Mesalazine—Crohn's disease	0.00106	0.00127	CcSEcCtD
Fentanyl—Face oedema—Prednisone—Crohn's disease	0.00106	0.00127	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00105	0.00127	CcSEcCtD
Fentanyl—Discomfort—Mesalazine—Crohn's disease	0.00105	0.00126	CcSEcCtD
Fentanyl—Irritability—Prednisone—Crohn's disease	0.00104	0.00126	CcSEcCtD
Fentanyl—Hypotension—Azathioprine—Crohn's disease	0.00104	0.00126	CcSEcCtD
Fentanyl—Cardiac arrest—Prednisone—Crohn's disease	0.00104	0.00125	CcSEcCtD
Fentanyl—Dry mouth—Mesalazine—Crohn's disease	0.00104	0.00125	CcSEcCtD
Fentanyl—Mood swings—Prednisone—Crohn's disease	0.00104	0.00125	CcSEcCtD
Fentanyl—Confusional state—Mesalazine—Crohn's disease	0.00102	0.00124	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00102	0.00123	CcSEcCtD
Fentanyl—Oedema—Mesalazine—Crohn's disease	0.00102	0.00123	CcSEcCtD
Fentanyl—Anaphylactic shock—Mesalazine—Crohn's disease	0.00102	0.00123	CcSEcCtD
Fentanyl—Infection—Mesalazine—Crohn's disease	0.00101	0.00122	CcSEcCtD
Fentanyl—Shock—Mesalazine—Crohn's disease	0.000999	0.00121	CcSEcCtD
Fentanyl—Nervous system disorder—Mesalazine—Crohn's disease	0.000996	0.0012	CcSEcCtD
Fentanyl—Hypokalaemia—Prednisone—Crohn's disease	0.000995	0.0012	CcSEcCtD
Fentanyl—Thrombocytopenia—Mesalazine—Crohn's disease	0.000994	0.0012	CcSEcCtD
Fentanyl—Tachycardia—Mesalazine—Crohn's disease	0.000991	0.0012	CcSEcCtD
Fentanyl—Skin disorder—Mesalazine—Crohn's disease	0.000986	0.00119	CcSEcCtD
Fentanyl—Hyperhidrosis—Mesalazine—Crohn's disease	0.000982	0.00118	CcSEcCtD
Fentanyl—Anorexia—Mesalazine—Crohn's disease	0.000968	0.00117	CcSEcCtD
Fentanyl—Muscular weakness—Prednisone—Crohn's disease	0.000964	0.00116	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000962	0.00116	CcSEcCtD
Fentanyl—Abdominal distension—Prednisone—Crohn's disease	0.000951	0.00115	CcSEcCtD
Fentanyl—Hypotension—Mesalazine—Crohn's disease	0.000949	0.00115	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000925	0.00112	CcSEcCtD
Fentanyl—Sweating increased—Prednisone—Crohn's disease	0.00092	0.00111	CcSEcCtD
Fentanyl—Feeling abnormal—Azathioprine—Crohn's disease	0.000919	0.00111	CcSEcCtD
Fentanyl—Insomnia—Mesalazine—Crohn's disease	0.000918	0.00111	CcSEcCtD
Fentanyl—Paraesthesia—Mesalazine—Crohn's disease	0.000912	0.0011	CcSEcCtD
Fentanyl—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000912	0.0011	CcSEcCtD
Fentanyl—Dyspnoea—Mesalazine—Crohn's disease	0.000905	0.00109	CcSEcCtD
Fentanyl—Somnolence—Mesalazine—Crohn's disease	0.000903	0.00109	CcSEcCtD
Fentanyl—Dyspepsia—Mesalazine—Crohn's disease	0.000894	0.00108	CcSEcCtD
Fentanyl—Neutropenia—Prednisone—Crohn's disease	0.000883	0.00107	CcSEcCtD
Fentanyl—Decreased appetite—Mesalazine—Crohn's disease	0.000883	0.00107	CcSEcCtD
Fentanyl—Body temperature increased—Azathioprine—Crohn's disease	0.000881	0.00106	CcSEcCtD
Fentanyl—Abdominal pain—Azathioprine—Crohn's disease	0.000881	0.00106	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000877	0.00106	CcSEcCtD
Fentanyl—Fatigue—Mesalazine—Crohn's disease	0.000875	0.00106	CcSEcCtD
Fentanyl—Erectile dysfunction—Prednisone—Crohn's disease	0.00087	0.00105	CcSEcCtD
Fentanyl—Constipation—Mesalazine—Crohn's disease	0.000868	0.00105	CcSEcCtD
Fentanyl—Pain—Mesalazine—Crohn's disease	0.000868	0.00105	CcSEcCtD
Fentanyl—Weight increased—Prednisone—Crohn's disease	0.00086	0.00104	CcSEcCtD
Fentanyl—Weight decreased—Prednisone—Crohn's disease	0.000855	0.00103	CcSEcCtD
Fentanyl—Hyperglycaemia—Prednisone—Crohn's disease	0.000852	0.00103	CcSEcCtD
Fentanyl—Depression—Prednisone—Crohn's disease	0.00084	0.00101	CcSEcCtD
Fentanyl—Feeling abnormal—Mesalazine—Crohn's disease	0.000837	0.00101	CcSEcCtD
Fentanyl—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00083	0.001	CcSEcCtD
Fentanyl—Neuropathy peripheral—Prednisone—Crohn's disease	0.000826	0.000997	CcSEcCtD
Fentanyl—Hypersensitivity—Azathioprine—Crohn's disease	0.000821	0.000991	CcSEcCtD
Fentanyl—Urticaria—Mesalazine—Crohn's disease	0.000807	0.000974	CcSEcCtD
Fentanyl—Abdominal pain—Mesalazine—Crohn's disease	0.000803	0.000969	CcSEcCtD
Fentanyl—Body temperature increased—Mesalazine—Crohn's disease	0.000803	0.000969	CcSEcCtD
Fentanyl—Bradycardia—Prednisone—Crohn's disease	0.00077	0.000929	CcSEcCtD
Fentanyl—Diarrhoea—Azathioprine—Crohn's disease	0.000763	0.000921	CcSEcCtD
Fentanyl—Haemoglobin—Prednisone—Crohn's disease	0.00076	0.000917	CcSEcCtD
Fentanyl—Haemorrhage—Prednisone—Crohn's disease	0.000756	0.000913	CcSEcCtD
Fentanyl—Hallucination—Prednisone—Crohn's disease	0.000752	0.000908	CcSEcCtD
Fentanyl—Hypersensitivity—Mesalazine—Crohn's disease	0.000748	0.000903	CcSEcCtD
Fentanyl—Connective tissue disorder—Prednisone—Crohn's disease	0.000743	0.000897	CcSEcCtD
Fentanyl—Dizziness—Azathioprine—Crohn's disease	0.000737	0.00089	CcSEcCtD
Fentanyl—Asthenia—Mesalazine—Crohn's disease	0.000729	0.000879	CcSEcCtD
Fentanyl—Pruritus—Mesalazine—Crohn's disease	0.000718	0.000867	CcSEcCtD
Fentanyl—Vomiting—Azathioprine—Crohn's disease	0.000709	0.000855	CcSEcCtD
Fentanyl—Eye disorder—Prednisone—Crohn's disease	0.000707	0.000853	CcSEcCtD
Fentanyl—Rash—Azathioprine—Crohn's disease	0.000703	0.000848	CcSEcCtD
Fentanyl—Dermatitis—Azathioprine—Crohn's disease	0.000702	0.000848	CcSEcCtD
Fentanyl—Flushing—Prednisone—Crohn's disease	0.000702	0.000847	CcSEcCtD
Fentanyl—Headache—Azathioprine—Crohn's disease	0.000698	0.000843	CcSEcCtD
Fentanyl—Diarrhoea—Mesalazine—Crohn's disease	0.000695	0.000839	CcSEcCtD
Fentanyl—Angiopathy—Prednisone—Crohn's disease	0.000686	0.000828	CcSEcCtD
Fentanyl—Immune system disorder—Prednisone—Crohn's disease	0.000683	0.000824	CcSEcCtD
Fentanyl—Arrhythmia—Prednisone—Crohn's disease	0.000676	0.000815	CcSEcCtD
Fentanyl—Dizziness—Mesalazine—Crohn's disease	0.000671	0.00081	CcSEcCtD
Fentanyl—Alopecia—Prednisone—Crohn's disease	0.000668	0.000807	CcSEcCtD
Fentanyl—Mental disorder—Prednisone—Crohn's disease	0.000662	0.0008	CcSEcCtD
Fentanyl—Nausea—Azathioprine—Crohn's disease	0.000662	0.000799	CcSEcCtD
Fentanyl—Malnutrition—Prednisone—Crohn's disease	0.000658	0.000795	CcSEcCtD
Fentanyl—Erythema—Prednisone—Crohn's disease	0.000658	0.000795	CcSEcCtD
Fentanyl—Vomiting—Mesalazine—Crohn's disease	0.000646	0.000779	CcSEcCtD
Fentanyl—Rash—Mesalazine—Crohn's disease	0.00064	0.000773	CcSEcCtD
Fentanyl—Dermatitis—Mesalazine—Crohn's disease	0.00064	0.000772	CcSEcCtD
Fentanyl—Headache—Mesalazine—Crohn's disease	0.000636	0.000768	CcSEcCtD
Fentanyl—Vision blurred—Prednisone—Crohn's disease	0.00062	0.000749	CcSEcCtD
Fentanyl—Ill-defined disorder—Prednisone—Crohn's disease	0.000611	0.000737	CcSEcCtD
Fentanyl—Anaemia—Prednisone—Crohn's disease	0.000608	0.000734	CcSEcCtD
Fentanyl—Agitation—Prednisone—Crohn's disease	0.000605	0.00073	CcSEcCtD
Fentanyl—Nausea—Mesalazine—Crohn's disease	0.000603	0.000728	CcSEcCtD
Fentanyl—Malaise—Prednisone—Crohn's disease	0.000594	0.000716	CcSEcCtD
Fentanyl—Vertigo—Prednisone—Crohn's disease	0.000591	0.000714	CcSEcCtD
Fentanyl—Syncope—Prednisone—Crohn's disease	0.00059	0.000713	CcSEcCtD
Fentanyl—Loss of consciousness—Prednisone—Crohn's disease	0.000579	0.000698	CcSEcCtD
Fentanyl—Convulsion—Prednisone—Crohn's disease	0.00057	0.000688	CcSEcCtD
Fentanyl—Hypertension—Prednisone—Crohn's disease	0.000568	0.000686	CcSEcCtD
Fentanyl—Arthralgia—Prednisone—Crohn's disease	0.00056	0.000676	CcSEcCtD
Fentanyl—Myalgia—Prednisone—Crohn's disease	0.00056	0.000676	CcSEcCtD
Fentanyl—Anxiety—Prednisone—Crohn's disease	0.000558	0.000674	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000557	0.000672	CcSEcCtD
Fentanyl—Discomfort—Prednisone—Crohn's disease	0.000554	0.000668	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisone—Crohn's disease	0.000537	0.000648	CcSEcCtD
Fentanyl—Oedema—Prednisone—Crohn's disease	0.000537	0.000648	CcSEcCtD
Fentanyl—Infection—Prednisone—Crohn's disease	0.000534	0.000644	CcSEcCtD
Fentanyl—Shock—Prednisone—Crohn's disease	0.000529	0.000638	CcSEcCtD
Fentanyl—Nervous system disorder—Prednisone—Crohn's disease	0.000527	0.000636	CcSEcCtD
Fentanyl—Tachycardia—Prednisone—Crohn's disease	0.000524	0.000633	CcSEcCtD
Fentanyl—Skin disorder—Prednisone—Crohn's disease	0.000522	0.00063	CcSEcCtD
Fentanyl—Hyperhidrosis—Prednisone—Crohn's disease	0.000519	0.000627	CcSEcCtD
Fentanyl—Anorexia—Prednisone—Crohn's disease	0.000512	0.000618	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.000497	0.00854	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000491	0.00844	CbGpPWpGaD
Fentanyl—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000489	0.000591	CcSEcCtD
Fentanyl—Insomnia—Prednisone—Crohn's disease	0.000486	0.000586	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000484	0.00832	CbGpPWpGaD
Fentanyl—Paraesthesia—Prednisone—Crohn's disease	0.000482	0.000582	CcSEcCtD
Fentanyl—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.000478	0.00822	CbGpPWpGaD
Fentanyl—Dyspepsia—Prednisone—Crohn's disease	0.000473	0.000571	CcSEcCtD
Fentanyl—Decreased appetite—Prednisone—Crohn's disease	0.000467	0.000564	CcSEcCtD
Fentanyl—Alfentanil—ALB—Crohn's disease	0.000465	0.404	CrCbGaD
Fentanyl—Fatigue—Prednisone—Crohn's disease	0.000463	0.000559	CcSEcCtD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000463	0.00796	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.000463	0.00796	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00046	0.0079	CbGpPWpGaD
Fentanyl—Constipation—Prednisone—Crohn's disease	0.000459	0.000555	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000452	0.00778	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000447	0.00768	CbGpPWpGaD
Fentanyl—Feeling abnormal—Prednisone—Crohn's disease	0.000443	0.000534	CcSEcCtD
Fentanyl—Gastrointestinal pain—Prednisone—Crohn's disease	0.000439	0.00053	CcSEcCtD
Fentanyl—Diphenhydramine—SLC22A5—Crohn's disease	0.000436	0.379	CrCbGaD
Fentanyl—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.000436	0.00749	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00043	0.0074	CbGpPWpGaD
Fentanyl—Urticaria—Prednisone—Crohn's disease	0.000427	0.000515	CcSEcCtD
Fentanyl—Body temperature increased—Prednisone—Crohn's disease	0.000425	0.000513	CcSEcCtD
Fentanyl—Abdominal pain—Prednisone—Crohn's disease	0.000425	0.000513	CcSEcCtD
Fentanyl—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.000422	0.00725	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00042	0.00723	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000397	0.00682	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisone—Crohn's disease	0.000396	0.000478	CcSEcCtD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000392	0.00673	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000391	0.00673	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.000388	0.00668	CbGpPWpGaD
Fentanyl—Asthenia—Prednisone—Crohn's disease	0.000385	0.000465	CcSEcCtD
Fentanyl—Pruritus—Prednisone—Crohn's disease	0.00038	0.000459	CcSEcCtD
Fentanyl—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000377	0.00648	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	0.000376	0.00646	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000369	0.00634	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.000368	0.00633	CbGpPWpGaD
Fentanyl—Diarrhoea—Prednisone—Crohn's disease	0.000368	0.000444	CcSEcCtD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000364	0.00625	CbGpPWpGaD
Fentanyl—Dizziness—Prednisone—Crohn's disease	0.000355	0.000429	CcSEcCtD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00035	0.00601	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.000344	0.00592	CbGpPWpGaD
Fentanyl—Vomiting—Prednisone—Crohn's disease	0.000342	0.000412	CcSEcCtD
Fentanyl—Rash—Prednisone—Crohn's disease	0.000339	0.000409	CcSEcCtD
Fentanyl—Dermatitis—Prednisone—Crohn's disease	0.000338	0.000408	CcSEcCtD
Fentanyl—Headache—Prednisone—Crohn's disease	0.000337	0.000406	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000335	0.00576	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000331	0.00569	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00033	0.00568	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.00032	0.00551	CbGpPWpGaD
Fentanyl—Nausea—Prednisone—Crohn's disease	0.000319	0.000385	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000312	0.00536	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000308	0.00529	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000307	0.00527	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.000302	0.00519	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.0003	0.00515	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000286	0.00492	CbGpPWpGaD
Fentanyl—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.000286	0.00492	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.000281	0.00483	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.000281	0.00483	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000279	0.0048	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000272	0.00467	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000272	0.00467	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00027	0.00464	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.000269	0.00463	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000264	0.00454	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000263	0.00452	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000259	0.00446	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.000255	0.00439	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.000255	0.00438	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000253	0.00434	CbGpPWpGaD
Fentanyl—Phenylbutazone—PTGS2—Crohn's disease	0.00025	0.217	CrCbGaD
Fentanyl—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.000246	0.00423	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.000237	0.00408	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.000236	0.00406	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000231	0.00398	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000228	0.00392	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.000228	0.00392	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.000224	0.00384	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000222	0.00382	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.000208	0.00358	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000205	0.00353	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.000201	0.00346	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.000201	0.00345	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.0002	0.00344	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.000199	0.00343	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000195	0.00336	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.000195	0.00335	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.000189	0.00325	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.000186	0.0032	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000185	0.00318	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.000181	0.00311	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.000177	0.00304	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.000176	0.00303	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.000171	0.00293	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.000169	0.00291	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000165	0.00283	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.000164	0.00283	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.000159	0.00273	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.000159	0.00273	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.000155	0.00267	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.000151	0.00259	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000149	0.00256	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000144	0.00248	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.000144	0.00248	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000144	0.00248	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.000139	0.0024	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.000138	0.00237	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000134	0.00231	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.000132	0.00227	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000131	0.00225	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.000129	0.00222	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000126	0.00217	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000126	0.00217	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000122	0.00209	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000121	0.00209	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000121	0.00208	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00012	0.00207	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000118	0.00202	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000117	0.00201	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000116	0.00199	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000114	0.00196	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000114	0.00195	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000113	0.00194	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000112	0.00192	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000109	0.00187	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000109	0.00187	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000107	0.00183	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000106	0.00183	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000106	0.00182	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	0.000105	0.00181	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000104	0.0018	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000104	0.00179	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000104	0.00179	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000103	0.00177	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000103	0.00177	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000102	0.00176	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000101	0.00174	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.0001	0.00172	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	9.95e-05	0.00171	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GPR65—Crohn's disease	9.71e-05	0.00167	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL1B—Crohn's disease	9.69e-05	0.00167	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	9.67e-05	0.00166	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.65e-05	0.00166	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	9.56e-05	0.00164	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	9.35e-05	0.00161	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR9—Crohn's disease	9.16e-05	0.00157	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	9.04e-05	0.00155	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	9e-05	0.00155	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTMR3—Crohn's disease	8.93e-05	0.00154	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	8.92e-05	0.00153	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL3—Crohn's disease	8.78e-05	0.00151	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	8.68e-05	0.00149	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GPR65—Crohn's disease	8.51e-05	0.00146	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	8.49e-05	0.00146	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	8.48e-05	0.00146	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.47e-05	0.00146	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	8.46e-05	0.00145	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	8.41e-05	0.00145	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	8.2e-05	0.00141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR9—Crohn's disease	7.74e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL3—Crohn's disease	7.7e-05	0.00132	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	7.64e-05	0.00131	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	7.59e-05	0.00131	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	7.45e-05	0.00128	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	7.35e-05	0.00126	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.33e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GPR65—Crohn's disease	7.19e-05	0.00124	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	7.17e-05	0.00123	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.15e-05	0.00123	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—Crohn's disease	7.03e-05	0.00121	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—FADS1—Crohn's disease	6.96e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	6.93e-05	0.00119	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR6—Crohn's disease	6.92e-05	0.00119	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	6.77e-05	0.00116	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GPX4—Crohn's disease	6.51e-05	0.00112	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL3—Crohn's disease	6.51e-05	0.00112	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.48e-05	0.00111	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTMR3—Crohn's disease	6.45e-05	0.00111	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	6.45e-05	0.00111	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	6.29e-05	0.00108	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GCKR—Crohn's disease	6.29e-05	0.00108	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RBX1—Crohn's disease	6.26e-05	0.00108	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	6.15e-05	0.00106	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	6.09e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR6—Crohn's disease	6.06e-05	0.00104	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	5.94e-05	0.00102	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.73e-05	0.000985	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	5.48e-05	0.000943	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RBX1—Crohn's disease	5.48e-05	0.000943	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	5.45e-05	0.000937	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	5.39e-05	0.000927	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	5.34e-05	0.000918	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	5.32e-05	0.000915	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL3—Crohn's disease	5.19e-05	0.000892	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.14e-05	0.000884	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR6—Crohn's disease	5.13e-05	0.000881	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—FADS1—Crohn's disease	5.03e-05	0.000865	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	5.02e-05	0.000863	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	5.02e-05	0.000863	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTMR3—Crohn's disease	4.87e-05	0.000838	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	4.81e-05	0.000827	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX4—Crohn's disease	4.71e-05	0.00081	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	4.66e-05	0.000802	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RBX1—Crohn's disease	4.64e-05	0.000797	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	4.56e-05	0.000784	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	4.55e-05	0.000783	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL3—Crohn's disease	4.55e-05	0.000782	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GCKR—Crohn's disease	4.55e-05	0.000782	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	4.54e-05	0.000782	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	4.51e-05	0.000776	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	4.4e-05	0.000756	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	4.33e-05	0.000745	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	4.15e-05	0.000714	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	4.13e-05	0.000711	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	4.06e-05	0.000699	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	3.99e-05	0.000686	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	3.99e-05	0.000685	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	3.94e-05	0.000678	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	3.92e-05	0.000675	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL3—Crohn's disease	3.84e-05	0.000661	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	3.8e-05	0.000653	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—FADS1—Crohn's disease	3.79e-05	0.000652	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	3.77e-05	0.000649	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	3.72e-05	0.000639	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	3.64e-05	0.000626	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	3.63e-05	0.000625	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	3.62e-05	0.000623	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX4—Crohn's disease	3.55e-05	0.000611	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.53e-05	0.000607	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.47e-05	0.000596	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	3.44e-05	0.000592	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCKR—Crohn's disease	3.43e-05	0.00059	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	3.37e-05	0.00058	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	3.37e-05	0.000579	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	3.31e-05	0.000569	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	3.21e-05	0.000552	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	3.19e-05	0.000548	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	3.08e-05	0.000529	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	3.06e-05	0.000527	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTMR3—Crohn's disease	3e-05	0.000516	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	2.91e-05	0.0005	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	2.8e-05	0.000481	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	2.69e-05	0.000463	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TYK2—Crohn's disease	2.56e-05	0.00044	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JAK2—Crohn's disease	2.44e-05	0.00042	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FADS1—Crohn's disease	2.34e-05	0.000402	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.33e-05	0.000401	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TYK2—Crohn's disease	2.24e-05	0.000386	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	2.23e-05	0.000383	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX4—Crohn's disease	2.19e-05	0.000376	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JAK2—Crohn's disease	2.14e-05	0.000368	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—Crohn's disease	2.12e-05	0.000364	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCKR—Crohn's disease	2.11e-05	0.000364	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—Crohn's disease	2e-05	0.000344	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	1.95e-05	0.000336	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TYK2—Crohn's disease	1.9e-05	0.000326	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—Crohn's disease	1.86e-05	0.00032	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JAK2—Crohn's disease	1.81e-05	0.000311	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—Crohn's disease	1.79e-05	0.000308	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.75e-05	0.000301	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	1.65e-05	0.000284	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—Crohn's disease	1.57e-05	0.00027	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—Crohn's disease	1.57e-05	0.00027	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—Crohn's disease	1.45e-05	0.000249	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—Crohn's disease	1.33e-05	0.000228	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.27e-05	0.000218	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—Crohn's disease	1.25e-05	0.000215	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—Crohn's disease	1.1e-05	0.000189	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—Crohn's disease	1.09e-05	0.000188	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—Crohn's disease	9.56e-06	0.000164	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—Crohn's disease	9.28e-06	0.00016	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—Crohn's disease	6.73e-06	0.000116	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—Crohn's disease	5.89e-06	0.000101	CbGpPWpGaD
